Holen Sie sich die Stockscreener-App
11.21
10.96%
-1.38
Schlusskurs vom Vortag:
$12.59
Offen:
$12.38
24-Stunden-Volumen:
2.86M
Relative Volume:
3.78
Marktkapitalisierung:
$190.08M
Einnahmen:
$53.74M
Nettoeinkommen (Verlust:
$33.24M
KGV:
4.2092
EPS:
2.6632
Netto-Cashflow:
$-27.40M
1W Leistung:
-14.36%
1M Leistung:
-12.90%
6M Leistung:
+211.39%
1J Leistung:
+237.65%
1-Tages-Spanne:
$10.81
$12.48
1-Wochen-Bereich:
$10.81
$14.43
52-Wochen-Spanne:
$1.5685
$15.02
Q 32 Bio Inc Stock (QTTB) Company Profile
Firmenname
Q 32 Bio Inc
Sektor
Branche
Telefon
781-999-0232
Adresse
830 WINTER STREET, WALTHAM
Compare QTTB vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QTTB
Q 32 Bio Inc
|
11.21 | 190.08M | 53.74M | 33.24M | -27.40M | 2.6632 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Q 32 Bio Inc Stock (QTTB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-02-11 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2025-02-11 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-12-11 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-12-11 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-12-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2024-12-11 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-10-24 | Eingeleitet | Raymond James | Strong Buy |
| 2024-09-11 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-17 | Eingeleitet | Guggenheim | Buy |
| 2024-05-21 | Eingeleitet | Leerink Partners | Outperform |
| 2024-04-11 | Eingeleitet | Oppenheimer | Outperform |
| 2024-04-02 | Eingeleitet | Piper Sandler | Overweight |
| 2023-07-28 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-02-22 | Bestätigt | BTIG Research | Neutral |
| 2022-02-22 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-02-22 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-03-02 | Eingeleitet | Stifel | Hold |
| 2020-12-14 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-08-11 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-25 | Fortgesetzt | BofA/Merrill | Buy |
| 2020-05-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-03-16 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-02-24 | Eingeleitet | Chardan Capital Markets | Buy |
| 2019-11-01 | Eingeleitet | Oppenheimer | Perform |
| 2019-09-10 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-04-12 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Q 32 Bio Inc Aktie (QTTB) Neueste Nachrichten
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Q32 Bio Inc. (QTTB) gains Boxer Capital group as 13.3% shareholder - Stock Titan
Q32 Bio to Report 36-Week Topline Results from Part B of SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata on July 13, 2026 - Yahoo Finance
Q32 Bio Inc.(NasdaqCM: QTTB) added to Russell Microcap Value Benchmark Index - marketscreener.com
Q32 Bio Inc.(NasdaqCM: QTTB) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Q32 Bio Inc.(NasdaqCM: QTTB) added to Russell 3000E Growth Benchmark - marketscreener.com
Q32 Bio Inc.(NasdaqCM: QTTB) added to Russell Microcap Index - marketscreener.com
Q32 Bio Inc.(NasdaqCM: QTTB) added to Russell 3000E Index - marketscreener.com
Q32 Bio Inc.(NasdaqCM: QTTB) added to Russell 3000E Value Benchmark - marketscreener.com
DB0 Forecast — Price Target — Prediction for 2027 - TradingView
Q32 Bio Inc Actuals & Estimates (MUN:DB0) - TradingView
Q32 Bio Inc Actuals & Estimates (NASDAQ:QTTB) - TradingView
Q32 Bio Inc Actuals & Estimates (BOATS:QTTB) - TradingView
Form S-3 Q32 Bio Inc For: 25 June By Investing.com - Investing.com Nigeria
Q32 Bio Files $300 Million Mixed Shelf - marketscreener.com
Q32 Bio (NASDAQ: QTTB) files $300M shelf; May 26 $55M placement noted - Stock Titan
Price to sales forward of Q32 Bio Inc. – NASDAQ:QTTB - TradingView
QTTB Forecast — Price Target — Prediction for 2027 - TradingView
Price to earnings forward of Q32 Bio Inc. – NASDAQ:QTTB - TradingView
Enterprise value to EBIT forward of Q32 Bio Inc. – NASDAQ:QTTB - TradingView
Enterprise value to revenue forward of Q32 Bio Inc. – NASDAQ:QTTB - TradingView
Q32 Bio Inc (QTTB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Why is Q32 Bio stock gaining Friday? - MSN
Q32 Bio Inc (QTTB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Q32 Bio Shareholders Back Directors, Auditor and Executive Pay - The Globe and Mail
Q32 Bio Inc (QTTB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Q32 Bio Inc (QTTB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Q32 Bio Inc (QTTB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Q32 Bio Inc (QTTB) Institutional Confidence - TradingKey
Q32 Bio Inc (QTTB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Director Kathleen LaPorte receives 9,810 Q32 Bio (QTTB) stock options - Stock Titan
Director Mark Iwicki of Q32 Bio (QTTB) awarded 9,810 options at $12.64 strike - Stock Titan
Director Isaac Manke receives 9,810 Q32 Bio (QTTB) stock options at $12.64 strike - Stock Titan
Q32 Bio (QTTB) director awarded 9,810 stock options at $12.64 strike - Stock Titan
Director at Q32 Bio (QTTB) receives 9,810 stock options tied to Atlas Venture - Stock Titan
Director Mary Thistle receives 9,810 Q32 Bio (QTTB) stock options at $12.64 - Stock Titan
Q32 Bio (QTTB) director gets 9,810 options at $12.64, benefits to OrbiMed - Stock Titan
Director at Q32 Bio (NASDAQ: QTTB) receives 9,810 stock options grant - Stock Titan
Q32 Bio Inc (QTTB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Q32 Bio Inc (QTTB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Q32 Bio Inc. (QTTB) Edges Lower, Consolidating Above Key Support LevelInstitutional Volume - newsline.com
QTTB: All proposals, including director elections and audit firm ratification, were approved - TradingView
QTTB News | Q32 BIO INC (NASDAQ:QTTB) - ChartMill
Atlas Venture fund discloses 625,000 Q32 Bio (QTTB) common shares held - Stock Titan
Q32 Bio Raises $55 Million in Private Placement - Global Legal Chronicle
ORBIMED ADVISORS LLC's Strategic Acquisition in Q32 Bio Inc - GuruFocus
Biotechnology Value Fund (QTTB) group reports 2.37M-share position, 150k warrants - Stock Titan
RA Capital affiliates disclose 2.33M-share stake in Q32 Bio (QTTB) - Stock Titan
Q32 Bio Inc. (QTTB) Tumbles 7% as Shares Nears Key Support ZoneContinuation Pattern Picks - newsline.com
Q32 Bio Inc. Stock (QTTB) Opinions on Massive Price Surge - Moomoo
Monday’s insider activity: Q32 Bio and Outlook see major buys By Investing.com - Investing.com South Africa
Finanzdaten der Q 32 Bio Inc-Aktie (QTTB)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):